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Abstract
Background: Prostaglandins (PG), produced by the uterine endometrium, are key regulators of several reproductive events,
including estrous cyclicity, implantation, pregnancy maintenance and parturition. Phospholipase A2 (PLA2) catalyzes the release
of arachidonic acid from membrane phospholipids, the rate-limiting step in PG biosynthesis. The bovine endometrial (BEND)
cell line has served as a model system for investigating regulation of signaling mechanisms involved in uterine PG production but
information concerning the specific PLA2 enzymes involved and their role in regulation of this process is limited. The objectives
of this investigation were to evaluate the expression and activities of calcium-dependent group IVA (PLA2G4A) and calcium-
independent group VI (PLA2G6) enzymes in the regulation of BEND cell PG production.
Methods: Cells were grown to near-confluence and treated with phorbol 12, 13 dibutyrate (PDBu), interferon-tau (IFNT), the
PLA2G4A inhibitor pyrrolidine-1 (PYR-1), the PLA2G6 inhibitor bromoenol lactone (BEL) and combinations of each.
Concentrations of PGF2alpha and PGE2 released into the medium were determined. Western blot analysis was performed on
cellular protein to determine effects of treatment on expression of PLA2G4A, PLA2G6 and PLA2G4C. PLA2 assays were
performed on intact cells by measuring arachidonic acid and linoleic acid release and group-specific PLA2 activity assays were
performed on cell lysates.
Results: BEND cells produced about 10-fold more PGE2 than PGF2alpha under resting conditions. Production of both PGs
increased significantly in response to PDBu-stimulation. PYR-1 significantly diminished production of both PGs by resting cells
and abolished the stimulatory effect of PDBu. BEL stimulated production of both PGs. IFNT reduced both PGE2 and PGF2alpha
production by resting cells and diminished PDBu stimulation of PG production. Conversely, IFNT did not significantly reduce
BEL stimulation of PG production. Cellular expression of PLA2G4A was enhanced by PDBu and this response was diminished
by IFNT. Expression of PLA2G6 was not observed to be affected by treatments and no PLA2G4C expression was observed.
Arachidonic acid release from intact cells was significantly increased by PDBu and this effect was attenuated by PYR-1 but not
by BEL. Release of linoleic acid from intact cells was stimulated by PDBu and inhibited by BEL but not PYR-1. Group specific
PLA2-activity assays demonstrated both PLA2G4A and PLA2G6 activity.
Conclusion: Results from this study demonstrate that PGE2 and PGF2-alpha production by BEND cells is mediated by the
activity and expression of PLA2G4A. Interferon-tau treatment diminished expression of PLA2G4A and PG production. BEND
cells were shown to express PLA2G6 but, unlike primary or early passage luminal bovine endometrial cells, stimulation of
PLA2G6 activity was not associated with increased PG production.
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Background
Prostaglandins, produced by the endometrial epithelium,
are important regulators of several reproductive processes,
including estrous cyclicity, implantation, pregnancy
maintenance and parturition [1]. Prostaglandin (PG) bio-
synthesis is dependent on arachidonic acid (AA) release
from membrane phospholipids catalyzed by phospholi-
pase A2 enzymes [reviewed in [2]]. Arachidonic acid is
then metabolized to intermediate products, PGG2 and
PGH2, by a cyclooxygenase reaction and by a peroxidase
reaction, respectively, both performed by cyclooxygenase
(COX) -1 and/or -2. Prostaglandin H2 is converted to bio-
active prostaglandins, such as PGF2α, PGE2, PGD2 and
PGI2, by terminal PG synthases, which may exhibit tissue
specific distribution [3].
Bovine and ovine endometrial explants and epithelial cell
cultures have proven to be functional models for analysis
of pathways that regulate PG biosynthesis. Early studies
used endometrial explants [4,5] or glandular endometrial
epithelial cells [5-7] harvested from animals at late die-
strus. More recent studies have utilized primary or early
passage luminal epithelial (LE) cells collected from ani-
mals early in the cycle (days 1–4) because the luminal epi-
thelium is the major site of endometrial PG production
and these cells exhibit much better growth characteristics
than LE cells collected during diestrus [8-11]. Results from
experiments with explants and glandular or luminal epi-
thelial cells are consistent; oxytocin stimulates PGF2α and
PGE2 production and interferon-tau (IFNT) diminishes
this response. Bovine endometrial epithelial cells produce
greater quantities of PGF2α than PGE2 and the PGF2α
response to oxytocin stimulation is stronger. The cellular
response to IFNT, alone, is biphasic. Low concentrations
(< 1 μg/ml) of IFNT diminish basal PG production and
high concentrations (>1 μg/ml) stimulate PG production
[10]. Interestingly, both low and high concentrations of
IFNT diminish oxytocin stimulated PG production. Ago-
nist-stimulated PG production, by oxytocin or high con-
centrations of IFNT, is associated with increased
expression of COX-2 mRNA and protein [9,10], prostag-
landin E2 synthase (PGES) [10], and prostaglandin F2α
synthase (PGFS) mRNA [11]. Attenuation of oxytocin-
stimulated PGF2α production is associated with decreased
COX-2 production [9,10] and alteration in the expression
of terminal PGF synthase [11].
Numerous studies on the regulation of PG biosynthesis
have been performed with the BEND, the bovine endome-
trial cell line [reviewed in [12]]. BEND cells have been
described as spontaneously immortalized endometrial
cells originally isolated from a cow on day 14 of the cycle
[13]. They have been described to have both epithelial-
like [12,13] and stromal-like [14] morphological charac-
teristics. BEND cells produce significantly more (10–20
fold) PGE2 than PGF2α under both resting and stimulated
conditions, and they respond to phorbol ester (phorbol
12-myristate 13-acetate, PMA, or phorbol 12,13 dibu-
tyrate, PDBu) stimulation, but not oxytocin stimulation,
with increased PG production [12,14,15]. Similar to pri-
mary endometrial epithelial cells, BEND cells increase
expression of COX-2 mRNA [16], protein and PGFS [15]
when PG production is stimulated and these responses are
diminished by IFNT at concentration less than 5 μg/ml
[15]. Unlike primary endometrial epithelial cells, BEND
cells are not stimulated to produce PGs by high levels of
IFNT alone and when treated with both PDBu and high
levels of IFNT (>5–20 μg/ml) inhibitory activities of IFNT
on PG production are ameliorated [15].
Despite the fact that phospholipase A2 (PLA2) catalyzes
the release of arachidonic acid, the rate-limiting step in PG
biosynthesis, most studies on the regulation of uterine PG
production have focused on expression and activation of
downstream enzymes such as cyclooxygenases, which cat-
alyze the committed step, and PG synthases. The reports
[6,9,16] that have included analysis of PLA2 expression in
domestic ruminant uterine PG production, focused on a
single enzyme, cPLA2α, (Group IVA PLA2 or PLA2G4A).
Interestingly, while none of these studies identified con-
sistent significant changes in expression of protein or
mRNA for PLA2G4A in association with alterations in PG
production, non-specific PLA2 inhibitors significantly
diminished basal and agonist-induced PG production
[6,9,17].
Mammalian PLA2s constitute a growing family of
enzymes, currently containing about 20 members, that
catalyze hydrolysis of fatty acids from the sn-2 position of
phospholipids with the concomitant formation of lyso-
phospholipid [18]. Based largely on structural and enzy-
matic properties, PLA2s have been grouped into four main
subfamilies: low molecular weight secretory PLA2s (PLA2
Groups 1–3, 5, 10 and 12); cytosolic PLA2G4; calcium
independent PLA2G6; and platelet activating factor (PAF)
acid hydrolases (PLA2G7 and PLA2G8). The intracellular
PLA2G4 and PLA2G6 enzymes are of particular interest in
the regulation of uterine PG biosynthesis because their
sites of action are the perinuclear membranes where
downstream AA metabolizing enzymes reside.
Recently, we characterized PLA2G4A, PLA2G4C and
PLA2G6 activity and expression in early passage bovine
luminal endometrial epithelial cells [19]. It was observed
that oxytocin stimulation of PGF2α production was associ-
ated with increased expression and activity of PLA2G6
and IFNT diminished these responses. In addition, the
PLA2G6 inhibitor, bromoenol lactone (BEL), abolished
oxytocin stimulation of PGF2α production. Results indi-
cated that oxytocin stimulation of endometrial PGF2α pro-
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duction is mediated, at least in part, through activation of
PLA2G6.
Both BEND cells and primary cultures of endometrial epi-
thelial cells have served as models for regulation of uter-
ine prostaglandin biosynthesis and the mechanism by
which IFNT modifies this process. Physiological differ-
ences between the two cell types have been identified
[14]. The objective of the present study was to determine
the role of PLA2 enzymes in BEND cell PG production and
relate these results to the reported differences between
BEND cells and primary endometrial epithelial cells.
Methods
BEND cells were a generous gift from Dr. T. Hansen
(Colorado State University, Ft Collins) and are commer-
cially available from American Type Culture Collection
(ATCC no. CRL-2398, Manassas, VA). Dulbecco mini-
mum essential medium (MEM), Ham's F-12, Hanks' bal-
anced salt solution (HBSS), gentamicin, oxytocin, PDBu,
bovine serum albumin, fetal bovine serum, horse serum,
aprotinin, leupeptin and pepstatin were from Sigma
Chemical Co (St Louis, MO). Enzyme Immunoassay kits
for PGE2 (catalog no. 900-001) and PGF2α (catalog no.
901-069) were from Assay Designs, Inc (Ann Arbor, MI).
1-palmitoyl-2-(1-14C) arachidonyl-phosphotidylcholine
(14 C-AA-PC), 1-palmitoyl-2-(1-14C) linoleoyl-phosphoti-
dylcholine (14C-LA-PC), 3H-arachidonic acid and 3H-lino-
leic acid were from American Radiolabeled Chemicals,
(St. Louis, MO). Group IVA PLA2 antibody (SC-454) was
from Santa Cruz Biotechnology, Inc (Santa Cruz, CA),
Group VI PLA2 antibody (Anti-iPLA2, #07-169) was from
Upstate Cell Signaling Solutions (Lake Placid, NY) and
the anti-Group IVC was a gift from Dr. C.C. Leslie (Uni-
versity of Colorado, Boulder, CO). Recombinant ovine
IFNT (antiviral activity, 1 × 10 8 U/mg) was donated
kindly by Dr. F.W. Bazer (Texas A&M University, College
Station, TX). Pyrrolidine-1 (PYR-1) was a generous gift of
Dr. Michael Gelb (University of Washington, Seattle WA).
Tissue culture plastic wares were from Becton Dickinson
and Co. (Franklin Lakes, NJ). Unless noted otherwise,
additional chemicals were from Sigma Chemical Corp.
Cell culture
BEND cells were cultured and propagated by the method
described by Staggs, et al. [13], with modest modifica-
tions. Briefly, cells were seeded into tissue culture dishes
of the appropriate size for each experiment (see below) at
a concentration of 0.5 × 105 cells per ml in culture
medium (40% Ham's F-12, 40% MEM, 200 U insulin/L,
50 μg gentamicin, 10% FBS, 10% horse serum) at 37°C in
a humidified atmosphere of 95% air and 5% CO2 and cul-
ture medium was changed every other day. For all experi-
ments, cells were grown to 80–90% confluence before
application of treatments which were applied in triplicate
and each experiment was repeated (n = 6) unless noted
otherwise.
PG assays
Cells were grown in 6-well plates, washed three times with
HBSS and cultured for 6 h in unsupplemented Ham's F-
12/MEM with the following treatments: vehicle control,
PDBu (100 ng/ml), IFNT (50 ng/ml), the PLA2G6 inhibi-
tor BEL (7.5 μM), the group PLA2G4A inhibitor PYR-1
(0.4 μM), PDBu + IFNT, PDBu + BEL, IFNT + BEL, PDBu
+ PYR-1. Vehicles, Ham's F-12/MEM for IFNT, and DMSO
for PDBu and the inhibitors, were added to each well. At
the end of the incubation period, medium was harvested
and stored frozen at -200 C. Prostaglandin F2α and E2
assays were performed with enzyme immunoassay kits
from Assay Designs, Inc., according to supplier's instruc-
tions. Inter- and intraassay coefficients of variation (n =
12) were 9% and 11%, respectively.
Western blot analysis
Western blot analysis was performed as described previ-
ously [20]. Briefly, cells were grown in 60 mm dishes and
treated with vehicle (control), PDBu and IFNT (50 ng and
1000 ng), alone and in combination for 6 h as described
above. Cells were lysed in RIPA buffer (50 mM Tris-HCl,
150 mM NaCl, 1% SDS, 0.5% sodium deoxycholate, 1
mM DTT, 100 μM PMSF, 1% NP-40), and 1 × protease
inhibitor cocktail (Roche Applied Science, Indianapolis,
IN). Lysates from triplicate treatment wells were com-
bined, sonicated and centrifuged (10,000 g, 20 minutes)
and supernatants were subjected to 10% SDS-polyacryla-
mide gel electrophoresis and transferred onto nitrocellu-
lose membranes. Non-specific binding sites were blocked
with 5% non-fat dry milk and membranes were incubated
with antibodies to PLA2G4A, PLA2G4C, and PLA2G6 in
1:800, 1:400 and 1:1000 dilutions, respectively, overnight
at 4°C. Membranes were rinsed 3 times and protein bands
were visualized by enhanced chemiluminescence (Amer-
sham Biosciences, Arlington Heights, IL). A blot was pre-
pared from each of the replicated experiments.
3H-arachidonic acid and 3H-linoleic acid released from 
intact cells
Intact cell PLA2 assays were performed on cells prelabeled
for 24 h with either 3H-arachidonic acid (3H-AA; 0.25
μCi/ml) or 3H-linoleic acid (3H-LA, 0.25 μCi/ml). Cells
were washed three times with Hank Balanced Salt Solu-
tion (HBSS), equilibrated for 45 min and treatments
applied for 1 hr. Cells were treated with 100 ng/ml PDBu
in the presence and absence of 7.5 μM BEL or 0.4 μM PYR-
1. Inhibitors were added 10 minutes prior to treatment
with PDBU. Medium and lysed cells were harvested sepa-
rately and % of total radioactivity released into the
medium determined by scintillation counting.
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PLA2 activity in cellular homogenates
PLA2 assays were performed as described previously [20].
Briefly, cells were washed and treated with either the
PLA2G4A inhibitor, PYR-1 (0.4 μM) or the PLA2G6 inhib-
itor BEL (7.5 μM) for 3 hours. At the end of the incubation
period, cells were washed with Ca++-free PBS containing 5
mM EGTA and 1 mM PMSF, lysed in homogenizing buffer
(50 mM Tris HCl, pH 7.4, 0.5 mM dithiothreitol, 20%
glycerol, 1 μg/ml leupeptin, 10 μg/ml aprotinin, 1 mM
phenylmethylsulfonylchloride) and sonicated two times
for 10 seconds on ice. The substrates 1-palmitoyl-2-[ara-
chidonoyl] phosphatidylcholine (cold AA-PC) and 1-
palmitoyl-2-[arachidonoyl-1-14C] phosphatidylcholine
(14C-AA-PC) or 1-palmitoyl-2-[linoleoyl] phosphatidyl-
choline (cold LA-PC), 1-palmitoyl-2-[linoleoyl-1-14C]
phosphatidlycholine (14C-LA-PC) were used to assay for
PLA2 activity. The substrates were dried under nitrogen
and resuspended by sonication in assay buffer (10 mM
Hepes, pH 7.5) to a final optimum concentration of cold
to radiolabeled substrate as determined previously. Cal-
cium-dependent activity (primarily PLA2G4A) assays
were performed with AA-PC and 14C-AA-PC in the pres-
ence of 5 mM CaCl2 and calcium-independent activity
(primarily PLA2G6 and PLA2G4C) assays were performed
using the same substrates but in the absence of CaCl2 and
the presence of EGTA (5 mM). Assays optimized for iden-
tification of PLA2G6 utilized LA-PC and 14C-LA-PC in
both the presence and absence of Ca++ and presence of
400 μM Triton-X and 0.8 mM ATP which enhance the
activity of this enzyme [29]. Experiments were terminated
by addition of chloroform-methanol, 2:1 (v/v), the chlo-
roform layer was extracted and lipids separated by thin-
layer chromatography (hexane: diethyl ether: glacial ace-
tic acid, 7:3:0.2). Lipids were visualized with I2 vapor, the
zones corresponding to fatty acid and phospholipids were
excised and radioactivity determined by scintillation
counting.
Statistical analysis
Data for PG production and PLA2 activity are presented as
means +/- SEM and subjected to least squares analysis of
variance using the general linear models procedure of the
Statistical Analysis System (SAS Institute, Cary, NC).
Sources of variance included experiments, treatments and
their interactions. Individual comparisons of means were
made using Student-Neuman-Keuls test in which the
independent variables were the treatments and the
dependent variables were the levels of PG or PLA2 activity
produced. Differences were considered statistically signif-
icant when p < 0.05.
Results
Prostaglandin production
Production of PGE2 and PGF2α are illustrated in Figures 1
and 2, respectively. BEND cells produced about 10-fold
more PGE2 than PGF2α under resting conditions. Produc-
tion of both PGs increased significantly (10- to 20-fold) in
Prostaglandin E2 production by BEND cellsFigure 1
Prostaglandin E2 production by BEND cells. Cell cul-
ture medium was harvested 6 h after addition of treatments 
and concentrations of PGE2 were analyzed by ELISA. Treat-
ments included: Control (C), IFNT (I), Pyrrolodine-1 (P), 
Bromoenol lactone (B), B +I, Phorbol 12, 13 dibutyrate (PD), 
PD + I, PD + P and PD + B. Treatments were performed in 
triplicate and repeated (n = 6). Data are expressed as means 
+/- SEM. Columns with different superscripts are significantly 
different (p < 0.05).
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Prostaglandin F2α production by BEND cellsFigure 2
Prostaglandin F2α production by BEND cells. Cell cul-
ture medium was harvested 6 h after addition of treatments 
and concentrations of PGF2α were analyzed by ELISA. Treat-
ments included: Control (C), IFNT (I), Pyrrolodine-1 (P), 
Bromoenol lactone (B), B + I, Phorbol 12, 13 dibutyrate 
(PD), PD + I, PD + P and PD + B. Treatments were per-
formed in triplicate and repeated (n = 6). Data are expressed 
as means +/- SEM. Columns with different superscripts are 
significantly different (p < 0.05).
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response to PDBu stimulation, which had a greater effect
on PGE2 production. PYR-1, the PLA2G4A inhibitor, sig-
nificantly diminished production of both PGs by resting
cells and abolished the stimulatory effect of PDBu. Inter-
estingly, BEL, the PLA2G6 inhibitor, stimulated produc-
tion of both PGs in control cells and PGF2α release in
PDBu-treated cells. IFNT reduced both PGE2 and PGF2α
production from resting cells and diminished PDBu stim-
ulation of PG production. Conversely, IFNT did not sig-
nificantly reduce BEL stimulation of PG production.
PLA2 protein expression
Western blot analysis of cellular proteins from BEND cells
demonstrated that the PLA2G4A antibody recognized a
protein that migrated at ~110 kD and a very minor pro-
tein of slightly less mass (~107 kD) that may have been a
breakdown product (Figure 3, top). The PLA2G6 antibody
cross-reacted with a protein that migrated at ~85 kD (Fig-
ure 3, bottom). The PLA2G4C antibody did not detect any
major protein bands (not shown). Two isoforms of
PLA2G6 were identified, a major band at 85 kD and a
minor band of slightly greater mass (~88 kD). Similar
results have been observed previously and are likely the
result of alternative splicing of the PLA2G6 transcript
resulting in multiple isoforms of the enzyme. Cells were
treated for 6 h with vehicle (control, lane 1), IFNT (50 ng/
ml, lane 2), IFNT (1000 ng/ml, lane 3), PDBu (lane 4),
PDBu plus IFNT (50 ng/ml, lane 5) or PDBu plus IFNT
(1000 ng/ml, lane 6) to determine effects of treatments on
PLA2 isoform expression. As illustrated in the representa-
tive Figure 3, IFNT, alone, had little effect on expression of
PLA2G4A when compared to control. In contrast PDBu
stimulated PLA2G4A expression and IFNT, when com-
bined with PDBu, diminished the stimulatory effect. Con-
versely, treatments had little effect on expression of
PLA2G6.
3H-arachidonic acid release and PLA2 activity assays
Release of incorporated3H-arachidonic acid and 3H-lino-
leic acid were used as measures of PLA2 activity in intact
cells because PLA2G4A is selective for arachidonic acid,
whereas PLA2G6 is non-selective and will cleave both ara-
chidonic acid and linoleic acid from membrane phos-
pholipids. As can be seen in Figure 4, PDBu induced
significant release of 3H-arachidonic acid when compared
to DMSO control. This effect was attenuated by the Group
IVA PLA2 inhibitor PYR-1, but not by the Group VI inhib-
itor, BEL. In contrast, PYR-1 had no effect on PDBu stim-
ulation of 3H-linoleic acid release (Figure 5) but BEL
inhibited this action.
As can be seen in Figure 6, BEND cells exhibited signifi-
cant PLA2 activity from cell lysates when 14C-PC-AA was
used as a substrate both in the presence or absence of cal-
cium; however, PLA2 activity was significantly greater in
the presence of calcium than in all other groups. The
PLA2G4A inhibitor, PYR-1, returned values to baseline in
both the presence or absence of calcium.
Cellular lysates also exhibited significant PLA2 activity
when 14C-PC-LA was used as a substrate and this activity
was not different in the presence or absence of calcium
(Figure 7). The PLA2G6 inhibitor, BEL, attenuated activity
in the presence of calcium and in the presence of EGTA.
BEND cell expression of PLA2G4A and PLA2G6Figure 3
BEND cell expression of PLA2G4A and PLA2G6. 
BEND cells were treated for 6 h with vehicle (control, lane 
1) 50 ng IFNT (lane 2), 1000 ng IFNT (lane 3), PDBu (lane 4), 
PDBu + 50 ng IFNT (lane 5) or 1000 ng IFNT + PDBu (lane 
6). Western blot analyses were performed on cellular pro-
teins using antibodies against A, PLA2G4A and B, PLA2G6 as 
described in Methods.
Arachidonic acid release by BEND cellsFigure 4
Arachidonic acid release by BEND cells. 3H-arachidonic 
acid (0.25 μCi/ml) was applied to cells for 24 h, cells were 
washed and treated for one h with vehicle (C, control), 
Phorbol 12,13 dibutyrate (PD), Bromoenol lactone (B), Pyr-
roline-1 (P), PD + B or PD + P. Medium and lysed cells were 
harvested separately and % of total radioactivity released into 
the medium determined by scintillation counting. Treatments 
were performed in triplicate and repeated (n = 6). Data are 
expressed as means +/- SEM. Columns with different super-
scripts are significantly different (p < 0,05).
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Discussion
The results from this investigation strongly indicate that
PLA2G4A is the enzyme that liberates arachidonic acid for
PG biosynthesis in BEND cells. In addition, the results
suggest that stimulation of PG production is regulated at
the level of PLA2G4A activity and expression. Several lines
of evidence support the concept that PG production is reg-
ulated by PLA2G4A in BEND cells. One, the PLA2G4A
inhibitor PYR-1, significantly diminished basal PG pro-
duction and abolished PDBu stimulation of PG produc-
tion and 3H-AA release from intact cells. Two, stimulation
of PG production by PDBu was associated with increased
expression and activity of PLA2G4A. Three, the predomi-
nant PLA2 activity in BEND cell lysates was calcium-
dependent. Also, BEND cells demonstrated significantly
more activity when 14C-PC-AA was used as a substrate
when compared to 14C-PC-LA, suggesting that the pre-
dominant isoform active in these cells is arachidonoyl-
selective, a characteristic of PLA2G4A. Finally, reduction
of PG production by IFNT was associated with diminished
PLA2G4A expression.
In addition to the demonstrated PLA2G4A activity, BEND
cells exhibited considerable PLA2G6 activity. The use of
14C-PC-LA as a substrate, showed activity was not different
in the presence or absence of calcium, consistent with cal-
cium-independent activity. This activity was inhibited by
BEL, suggesting activity of a PLA2G6 isoform. Similarly,
BEL, but not PYR-1, inhibited incorporated 3H-linoleic
acid release from intact cells. However, BEL was not inhib-
Linoleic acid release by BEND cellsFigure 5
Linoleic acid release by BEND cells. 3H-linoleic acid 
(0.25 μCi/ml) was applied to cells for 24 h, cells were washed 
and treated for one h with vehicle, (C, control), Phorbol 
12,13 dibutyrate (PD), Bromoenol lactone (B), Pyrrolodine-1 
(P), PD + B or PD + P. Medium and lysed cells were har-
vested separately and % of total radioactivity released into 
medium determined by scintillation counting. Treatments 
were performed in triplicate and repeated (n = 6). Data are 
expressed as means +/- SEM. Columns with different super-
scripts are significantly different (p < 0.05).
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PLA2 activity assays using AA-PC as substrateFigure 6
PLA2 activity assays using AA-PC as substrate. Ca++-
dependent PLA2 activity assays were performed on cellular 
lysates with AA-PC and 14C-AA-PC in the presence of 5 mM 
CaCl2 and Ca++-independent assays were performed using 
the same substrate but in the absence of Ca++ and the pres-
ence of 5 mM EGTA. Columns with different superscripts 
are significantly different (p < 0.05). The PLA2G4A inhibitor, 
pyrroline-1 (PYR-1) inhibited Ca++-dependent activity.
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PLA2 activity assays using LA-PC as substrate. Ca++-
dependent activity assays were performed on cellular lysates 
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and Ca++-independent assays were performed using the same 
substrate but in the absence of Ca++ and the presence of 5 
mM EGTA. Columns with different superscripts are signifi-
cantly different (p < 0.05). The PLA2G6-inhibitor, bromoenol 
lactone (BEL), was inhibitory to PLA2 activity toward LA-PC.
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itory to BEND cell PG synthesis, an indication that
PLA2G6 activation does not promote PG production in
these cells. PLA2G6 has been shown to be involved in
maintaining membrane homeostasis in some cell types
[18] and it is feasible that it plays a similar role in BEND
cells. Interestingly, inhibition of PLA2G6 activity with BEL
resulted in increased production of both PGF2α and
PGE2 and BEL was synergistic with PDBu in promoting
production of PGF2α. In previous studies with primary or
early passage luminal endometrial cells, we observed that
BEL stimulated PGE2 production and inhibited PGF2α
production [19]. Whereas BEND cell PGF2α and PGE2
production appears to be mediated by PLA2G4A, oxy-
tocin-stimulated luminal endometrial cell PGF2α produc-
tion was associated with activation of PLA2G6. In BEND
cells, inhibition of PLA2G6 activity by BEL may result in
greater concentrations of phospholipid substrate availa-
ble for hydrolysis by PLA2G4A resulting in increased pro-
duction of both PGF2α and PGE2.
Several studies have used BEND cells as a model system
for investigation of signaling mechanisms involved in
uterine cell PG production and IFNT inhibition of this
process [reviewed in [12]]. Base on results from these
studies, it was concluded that phorbol ester-stimulation
of PG production and reduction of this effect, by IFNT,
was mediated by positive and negative regulation of COX-
2 expression. For example, Binelli et al. [16] reported that
activation of the protein kinase C (PKC) pathway with
PDBu increased COX-2 expression and PGF2α production.
Pru et al. [23] observed that PDBu treatment stimulated
COX-2 mRNA expression within 30–60 minutes, while
COX-2 protein and PG production increased at 3 hr. Co-
treatment of cells with IFNT and PDBu results in dimin-
ished COX-2 mRNA, COX-2 protein and PG production.
One study [16] observed that PDBu tended to increase (p
< 1.0) PLA2 protein expression and IFNT tended to dimin-
ish this response, but only after 12 hours of culture, but
PLA2 activity was not evaluated. In the present study, we
observed an increase in PLA2 at 6 hours, the only time
point tested, and maximal rate of increase in PLA2activity
at 3 hours. In preliminary studies, an hourly time course
of PLA2 activity was performed (not shown) and signifi-
cant increases were observed in the first hour reaching a
maximum rate of increase at 3 hours. These results indi-
cate that increases in PLA2 activity in response to PDBu is
an early response, while the increase in PLA2 expression is
a delayed response. Based on these, and previous results
[19], it is suggested that uterine PG production is regu-
lated, at least in part, at the level of PLA2 activity and
expression.
Stimulation of BEND cells with PDBu results in the phos-
phorylation and activation of several components of
mitogen activated protein kinase (MAPK) pathways
[23,24]. It is well established in a variety of cell types that
MAPKs phosphorylate and activate PLAG4A resulting in
arachidonic acid release [2]. Arachidonic acid, in addition
to being the major prostaglandin precursor, can act as a
signaling molecule and affects intracellular Ca++ concen-
trations [25]. Importantly, arachidonic acid up-regulates
COX-2 expression and PG production in a variety of cell
types [26,27]. Parent, et al. [28], demonstrated that exog-
enous arachidonic acid stimulates COX-2 expression fol-
lowed by a 30-fold increase in PG production by bovine
endometrial epithelial cells. In BEND cells, arachidonic
acid enhanced PGF2α production in PDBu-stimulated
cells [29]. It is suggested that PDBu-activation of the PKC/
MAPK pathway results in increased activity and expression
of PLA2G4A which liberates arachidonic acid from peri-
nuclear membranes. Endogenous arachidonic acid then
may serve both as substrate for, and inducer of, COX-2
which completes the committed step in PG biosynthesis.
Our results demonstrating phorbol ester stimulation of
PLA2G4A activity and expression do not preclude the pos-
sibility of similar actions on COX-2 expression. Hughes-
Fulford et al. [27] suggested that activation of PLA2G4A
expression may involve signaling mechanisms similar to
those of COX-2, since the genes have several identical pro-
moter elements and the genes are on the same region of
the same chromosome, in mice and humans. The genes
for PLA2G4 and COX-2 are located in the same region of
chromosome 16 in cattle [30] and review of the promoter
region revealed several promoter elements in common.
This raises the possibility that the two genes may be co-
regulated, a phenomenon observed by others [31].
The mechanism by which IFNT exerts negative regulation
on PG production in BEND cells is unclear. Guzeloglu, et
al, [24] investigated effects of IFNT on COX-2 mRNA sta-
bility and concluded that IFNT may diminish PDBu-stim-
ulated PG production by accelerating COX-2 degradation,
mediated through an unidentified transcription depend-
ent mechanism. Thatcher, et al, [12] suggested that IFNT,
acting through Type I IFN receptors, activates the Janus
kinase (JAK)-signal transducer and activator of transcrip-
tion (STAT) pathway in a manner that directly represses
COX-2 expression. Our results indicate that IFNT dimin-
ishes PLA2G4A expression, which would, in turn, reduce
arachidonic acid release potentially resulting in dimin-
ished COX-2 expression and PG production. As indicated
above, COX-2 and PLA2G4A gene expression may be co-
regulated since the promoter region of each share com-
mon elements, including IFN response elements [12,32].
Results from the present study with BEND cells differ from
results of our previous study with bovine luminal
endometrial epithelial cells [19]. Similar to studies by oth-
ers [14] BEND cells produced 10–20 fold more PGE2 than
PGF2α, whereas luminal endometrial epithelial cells pro-
Reproductive Biology and Endocrinology 2008, 6:44 http://www.rbej.com/content/6/1/44
Page 8 of 9
(page number not for citation purposes)
duce greater quantities of the latter. PDBu stimulation of
BEND cell PG production did not affect PLA2G6 expres-
sion or activity and the PLA2G6 inhibitor, bromoenol lac-
tone, did not diminish BEND cell PG production.
Conversely, stimulation of PGF2α production with oxy-
tocin in luminal endometrial epithelial cells increased
PLA2G6 expression and activity and this response was
attenuated by bromoenol lactone. In BEND cells, the
PLA2G4A inhibitor, PYR-1, diminished PG production in
unstimulated cells and abolished PDBu stimulation of PG
production whereas it had little effect on luminal
endometrial epithelial cell PG production (Ochs, Roberts,
Elgayyer, Godkin and Tithof, unpublished observation).
Together, these results indicate that PG production by the
two cell types may be regulated by different PLA2 isotypes.
Another possible explanation for the discordant results
may be that stimulation with a phorbol ester may result in
activation of signal transduction pathways different from
those activated by oxytocin.
Conclusion
PGE2 and PGF2-alpha production by BEND cells is medi-
ated by the activity and expression of PLA2G4A. Interferon-
tau treatment diminished expression of PLA2G4A and PG
production. BEND cells were shown to express PLA2G6
but, unlike primary or early passage luminal bovine
endometrial cells, stimulation of PLA2G6 activity was not
associated with increased PG production. Identification of
PLA2 enzymes as key regulators of PG production may lead
to novel methods of regulating prostanoid production.
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